Captopril and quinapril reduce reactive oxygen species
- 29 October 2002
- journal article
- research article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 32 (10) , 732-737
- https://doi.org/10.1046/j.1365-2362.2002.01064.x
Abstract
Background Angiotensin‐converting enzyme inhibitors may affect reactive oxygen species in humans in vitro and in vivo. In the present study we evaluated whether angiotensin‐converting enzyme inhibito...Keywords
This publication has 29 references indexed in Scilit:
- Increased intracellular reactive oxygen species in patients with end-stage renal failure: Effect of hemodialysisKidney International, 2000
- Quest for FireArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Vascular NADH/NADPH Oxidase Is Involved in Enhanced Superoxide Production in Spontaneously Hypertensive RatsHypertension, 2000
- Superoxide Anion Production Is Increased in a Model of Genetic HypertensionHypertension, 1999
- Angiotensin II induces superoxide anion production by mesangial cellsKidney International, 1998
- Antioxidant power of angiotensin‐converting enzyme inhibitors in vitroBritish Journal of Clinical Pharmacology, 1998
- Antioxidant and Prooxidant Properties of Captopril and EnalaprilFree Radical Biology & Medicine, 1997
- Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.Journal of Clinical Investigation, 1996
- p22 Is a Critical Component of the Superoxide-generating NADH/NADPH Oxidase System and Regulates Angiotensin IIinduced Hypertrophy in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1996
- Influence of Food on the Pharmacokinetics of Quinapril and Its Active Diacid Metabolite, CI-928The Journal of Clinical Pharmacology, 1987